MS & PHD STUDENTS

Steven Warner, PhD

Degree: 
PhD
Program: 
Pharmaceutical Sciences
Track: 
Drug Discovery and Development
Dissertation Title: 
"Targeting the Aurora Kinases to Treat Pancreatic Cancer"

Alumnus
Year Graduated: 2005
Career Type: Industry
Manager, Discovery Biology, SuperGen, Inc., Salt Lake City, UT

Academic & Professional Updates
My research in the Medicinal and Natural Products Chemistry Program focused on the validation and drug targeting of the Aurora kinases to treat cancer. I used genetic and pharmacological approaches to perturb the Aurora kinase signaling pathway in order to understand the biological consequences and potential clinical outcomes of an Aurora-targeted therapy. Additionally, I employed a structure-based approach to design and develop a novel class of small molecule Aurora kinase inhibitors. I am currently a manager in Discovery Biology at SuperGen, Inc.

Publications
1. S.L. Warner, H. Han, D.J. Bearss and D.D. Von Hoff. Targeting Aurora-2 kinase in cancer. Molecular Cancer Therapeutics 2: 589–595 (2003).
Originally posted: August 21, 2014
Last updated: December 21, 2016
Want to update? Contact Webmaster
Share This